Inhaled sirolimus trial aims to ease breathing in lung scar patients
Disease control
Recruiting now
This Phase 2 trial tests an inhaled drug called LAM-001 (sirolimus) in 85 adults who have pulmonary hypertension (high blood pressure in the lungs) along with interstitial lung disease (lung scarring). The study compares the drug to a placebo to see if it improves blood flow in t…
Phase: PHASE2 • Sponsor: OrphAI Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC